Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone for acute otitis media in children
ACTRN12618000049279Phase 3Completed
- Sponsor
- Respati Wulansari Ranakusuma
- Start
- Mar 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of prednisolone in acute otitis media (AOM) (4 arms), sponsored by Respati Wulansari Ranakusuma. Primary endpoints: Recruitment rates, Success of study procedures and 1 more. Started Mar 2018; status: completed.
02
Drugs
prednisolone
03
Conditions
acute otitis media (AOM)
Beyond the preview
Go deeper on ACTRN12618000049279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000049279.